A Hybrid Rehabilitation Program for Adults with Peripheral Artery Disease (HY-PAD): A Pre-Post Intervention Study to Assess Its Feasibility
Supervised exercise programs improve walking impairment and quality of life (QoL) in patients with peripheral artery disease (PAD). However, such programs are underutilized, due to their limited accessibility. A feasible and effective exercise program is needed. This study assessed the feasibility o...
Uložené v:
| Vydané v: | CJC open (Online) Ročník 7; číslo 1; s. 110 - 119 |
|---|---|
| Hlavní autori: | , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Elsevier Inc
01.01.2025
Elsevier |
| Predmet: | |
| ISSN: | 2589-790X, 2589-790X |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Supervised exercise programs improve walking impairment and quality of life (QoL) in patients with peripheral artery disease (PAD). However, such programs are underutilized, due to their limited accessibility. A feasible and effective exercise program is needed. This study assessed the feasibility of a hybrid onsite and home-based exercise program (HY-PAD) and changes in walking capacity and PAD-specific QoL following HY-PAD.
Due to recruitment challenges imposed by the COVID-19 pandemic, this randomized controlled trial was modified to a pre–post intervention design that excluded the control group. Eligible patients with PAD were assigned to HY-PAD, consisting of 1-hour, supervised onsite exercise sessions 3 days per week for 4 weeks, followed by a home-based program with weekly 15-minute telephone calls to discuss exercise planning for 8 weeks. Feasibility was determined based on recruitment, adherence, and adverse events. Walking capacity was measured by a 6-minute walk test. PAD-specific QoL was assessed using the Walking Impairment Questionnaire.
Of 24 patients enrolled (3 women, aged 70 ± 8 years), 21 (87.5%) completed HY-PAD. Twenty participants attended ≥ 87.5% of prescribed sessions. Two participants experienced adverse events (foot injury and limb ischemia). The 6-minute walk test distance (357 ± 105 vs 413 ± 53 meters, P = 0.021), and 2 domains of the questionnaires (walking speed: 38.4 ± 24.1 vs 60.6 ± 26.6 points and stair-climbing: 60.6 ± 29.4 vs 74.0 ± 23.1 points, both P < 0.001) increased significantly.
High attendance and low dropout rates support the feasibility of using HY-PAD, which was associated with improved walking capacity and PAD-specific QoL. Future studies are warranted to confirm its efficacy.
Des programmes d’exercice supervisés atténuent la difficulté à la marche et améliorent la qualité de vie chez les patients atteints d’artériopathie périphérique. Cependant, de tels programmes sont sous-utilisés, car ils sont peu accessibles. Un programme d’exercice faisable et efficace est nécessaire. Cette étude visait à évaluer la faisabilité d’un programme d’exercice hybride, soit en centre et à domicile, ainsi que les modifications dans la capacité de marcher et dans la qualité de vie spécifique de l’artériopathie périphérique après un programme d’exercice hybride.
En raison des difficultés d’inscription liées à la pandémie de COVID-19, le plan de cet essai contrôlé à répartition aléatoire a été modifié pour comprendre une évaluation pré- et post-intervention qui excluait le groupe témoin. Des patients atteints d’une artériopathie périphérique admissibles ont été inscrits au programme d’exercice hybride en centre et à domicile consistant en des séances d’exercice d’une heure supervisées dans un centre 3 jours par semaine durant 4 semaines, ainsi qu’un programme basé au domicile des patients, comportant des appels téléphoniques hebdomadaires de 15 minutes pour discuter de la planification des exercices, durant 8 semaines. La faisabilité a été déterminée sur la base des inscriptions, de l’adhésion des patients et des effets indésirables. La capacité de marcher a été mesurée à l’aide d’un test de marche de 6 minutes. La qualité de vie spécifique de l’artériopathie périphérique a été évaluée à l’aide du questionnaire WIQ (Walking Impairment Questionnaire).
Parmi les 24 patients inscrits (3 femmes; âgés de 70 ± 8 ans), 21 (87,5 %) se sont rendus à la fin du programme d’exercice hybride en centre et à domicile. Vingt participants ont assisté à au moins 87,5 % des séances prévues. Deux participants ont connu des effets indésirables (lésion au pied et ischémie d’un membre). La distance au test de marche de 6 minutes (357 ± 105 vs 413 ± 53 mètres, p = 0,021) et 2 domaines des questionnaires (vitesse de la marche : 38,4 ± 24,1 vs 60,6 ± 26,6 points et montée des marches : 60,6 ± 29,4 vs 74,0 ± 23,1 points, p < 0,001 pour les deux) ont augmenté considérablement.
La participation élevée et le faible taux d’abandons appuient la faisabilité des programmes d’exercice hybride en centre et à domicile, lesquels ont été associés à une amélioration de la marche et de la qualité de vie liée à l’artériopathie périphérique. De futures études sont nécessaires pour en confirmer l’efficacité. |
|---|---|
| AbstractList | Supervised exercise programs improve walking impairment and quality of life (QoL) in patients with peripheral artery disease (PAD). However, such programs are underutilized, due to their limited accessibility. A feasible and effective exercise program is needed. This study assessed the feasibility of a hybrid onsite and home-based exercise program (HY-PAD) and changes in walking capacity and PAD-specific QoL following HY-PAD.BackgroundSupervised exercise programs improve walking impairment and quality of life (QoL) in patients with peripheral artery disease (PAD). However, such programs are underutilized, due to their limited accessibility. A feasible and effective exercise program is needed. This study assessed the feasibility of a hybrid onsite and home-based exercise program (HY-PAD) and changes in walking capacity and PAD-specific QoL following HY-PAD.Due to recruitment challenges imposed by the COVID-19 pandemic, this randomized controlled trial was modified to a pre-post intervention design that excluded the control group. Eligible patients with PAD were assigned to HY-PAD, consisting of 1-hour, supervised onsite exercise sessions 3 days per week for 4 weeks, followed by a home-based program with weekly 15-minute telephone calls to discuss exercise planning for 8 weeks. Feasibility was determined based on recruitment, adherence, and adverse events. Walking capacity was measured by a 6-minute walk test. PAD-specific QoL was assessed using the Walking Impairment Questionnaire.MethodsDue to recruitment challenges imposed by the COVID-19 pandemic, this randomized controlled trial was modified to a pre-post intervention design that excluded the control group. Eligible patients with PAD were assigned to HY-PAD, consisting of 1-hour, supervised onsite exercise sessions 3 days per week for 4 weeks, followed by a home-based program with weekly 15-minute telephone calls to discuss exercise planning for 8 weeks. Feasibility was determined based on recruitment, adherence, and adverse events. Walking capacity was measured by a 6-minute walk test. PAD-specific QoL was assessed using the Walking Impairment Questionnaire.Of 24 patients enrolled (3 women, aged 70 ± 8 years), 21 (87.5%) completed HY-PAD. Twenty participants attended ≥ 87.5% of prescribed sessions. Two participants experienced adverse events (foot injury and limb ischemia). The 6-minute walk test distance (357 ± 105 vs 413 ± 53 meters, P = 0.021), and 2 domains of the questionnaires (walking speed: 38.4 ± 24.1 vs 60.6 ± 26.6 points and stair-climbing: 60.6 ± 29.4 vs 74.0 ± 23.1 points, both P < 0.001) increased significantly.ResultsOf 24 patients enrolled (3 women, aged 70 ± 8 years), 21 (87.5%) completed HY-PAD. Twenty participants attended ≥ 87.5% of prescribed sessions. Two participants experienced adverse events (foot injury and limb ischemia). The 6-minute walk test distance (357 ± 105 vs 413 ± 53 meters, P = 0.021), and 2 domains of the questionnaires (walking speed: 38.4 ± 24.1 vs 60.6 ± 26.6 points and stair-climbing: 60.6 ± 29.4 vs 74.0 ± 23.1 points, both P < 0.001) increased significantly.High attendance and low dropout rates support the feasibility of using HY-PAD, which was associated with improved walking capacity and PAD-specific QoL. Future studies are warranted to confirm its efficacy.ConclusionsHigh attendance and low dropout rates support the feasibility of using HY-PAD, which was associated with improved walking capacity and PAD-specific QoL. Future studies are warranted to confirm its efficacy. Supervised exercise programs improve walking impairment and quality of life (QoL) in patients with peripheral artery disease (PAD). However, such programs are underutilized, due to their limited accessibility. A feasible and effective exercise program is needed. This study assessed the feasibility of a hybrid onsite and home-based exercise program (HY-PAD) and changes in walking capacity and PAD-specific QoL following HY-PAD. Due to recruitment challenges imposed by the COVID-19 pandemic, this randomized controlled trial was modified to a pre–post intervention design that excluded the control group. Eligible patients with PAD were assigned to HY-PAD, consisting of 1-hour, supervised onsite exercise sessions 3 days per week for 4 weeks, followed by a home-based program with weekly 15-minute telephone calls to discuss exercise planning for 8 weeks. Feasibility was determined based on recruitment, adherence, and adverse events. Walking capacity was measured by a 6-minute walk test. PAD-specific QoL was assessed using the Walking Impairment Questionnaire. Of 24 patients enrolled (3 women, aged 70 ± 8 years), 21 (87.5%) completed HY-PAD. Twenty participants attended ≥ 87.5% of prescribed sessions. Two participants experienced adverse events (foot injury and limb ischemia). The 6-minute walk test distance (357 ± 105 vs 413 ± 53 meters, P = 0.021), and 2 domains of the questionnaires (walking speed: 38.4 ± 24.1 vs 60.6 ± 26.6 points and stair-climbing: 60.6 ± 29.4 vs 74.0 ± 23.1 points, both P < 0.001) increased significantly. High attendance and low dropout rates support the feasibility of using HY-PAD, which was associated with improved walking capacity and PAD-specific QoL. Future studies are warranted to confirm its efficacy. Des programmes d’exercice supervisés atténuent la difficulté à la marche et améliorent la qualité de vie chez les patients atteints d’artériopathie périphérique. Cependant, de tels programmes sont sous-utilisés, car ils sont peu accessibles. Un programme d’exercice faisable et efficace est nécessaire. Cette étude visait à évaluer la faisabilité d’un programme d’exercice hybride, soit en centre et à domicile, ainsi que les modifications dans la capacité de marcher et dans la qualité de vie spécifique de l’artériopathie périphérique après un programme d’exercice hybride. En raison des difficultés d’inscription liées à la pandémie de COVID-19, le plan de cet essai contrôlé à répartition aléatoire a été modifié pour comprendre une évaluation pré- et post-intervention qui excluait le groupe témoin. Des patients atteints d’une artériopathie périphérique admissibles ont été inscrits au programme d’exercice hybride en centre et à domicile consistant en des séances d’exercice d’une heure supervisées dans un centre 3 jours par semaine durant 4 semaines, ainsi qu’un programme basé au domicile des patients, comportant des appels téléphoniques hebdomadaires de 15 minutes pour discuter de la planification des exercices, durant 8 semaines. La faisabilité a été déterminée sur la base des inscriptions, de l’adhésion des patients et des effets indésirables. La capacité de marcher a été mesurée à l’aide d’un test de marche de 6 minutes. La qualité de vie spécifique de l’artériopathie périphérique a été évaluée à l’aide du questionnaire WIQ (Walking Impairment Questionnaire). Parmi les 24 patients inscrits (3 femmes; âgés de 70 ± 8 ans), 21 (87,5 %) se sont rendus à la fin du programme d’exercice hybride en centre et à domicile. Vingt participants ont assisté à au moins 87,5 % des séances prévues. Deux participants ont connu des effets indésirables (lésion au pied et ischémie d’un membre). La distance au test de marche de 6 minutes (357 ± 105 vs 413 ± 53 mètres, p = 0,021) et 2 domaines des questionnaires (vitesse de la marche : 38,4 ± 24,1 vs 60,6 ± 26,6 points et montée des marches : 60,6 ± 29,4 vs 74,0 ± 23,1 points, p < 0,001 pour les deux) ont augmenté considérablement. La participation élevée et le faible taux d’abandons appuient la faisabilité des programmes d’exercice hybride en centre et à domicile, lesquels ont été associés à une amélioration de la marche et de la qualité de vie liée à l’artériopathie périphérique. De futures études sont nécessaires pour en confirmer l’efficacité. AbstractBackgroundSupervised exercise programs improve walking impairment and quality of life (QoL) in patients with peripheral artery disease (PAD). However, such programs are underutilized, due to their limited accessibility. A feasible and effective exercise program is needed. This study assessed the feasibility of a hybrid onsite and home-based exercise program (HY-PAD) and changes in walking capacity and PAD-specific QoL following HY-PAD. MethodsDue to recruitment challenges imposed by the COVID-19 pandemic, this randomized controlled trial was modified to a pre–post intervention design that excluded the control group. Eligible patients with PAD were assigned to HY-PAD, consisting of 1-hour, supervised onsite exercise sessions 3 days per week for 4 weeks, followed by a home-based program with weekly 15-minute telephone calls to discuss exercise planning for 8 weeks. Feasibility was determined based on recruitment, adherence, and adverse events. Walking capacity was measured by a 6-minute walk test. PAD-specific QoL was assessed using the Walking Impairment Questionnaire. ResultsOf 24 patients enrolled (3 women, aged 70 ± 8 years), 21 (87.5%) completed HY-PAD. Twenty participants attended ≥ 87.5% of prescribed sessions. Two participants experienced adverse events (foot injury and limb ischemia). The 6-minute walk test distance (357 ± 105 vs 413 ± 53 meters, P = 0.021), and 2 domains of the questionnaires (walking speed: 38.4 ± 24.1 vs 60.6 ± 26.6 points and stair-climbing: 60.6 ± 29.4 vs 74.0 ± 23.1 points, both P < 0.001) increased significantly. ConclusionsHigh attendance and low dropout rates support the feasibility of using HY-PAD, which was associated with improved walking capacity and PAD-specific QoL. Future studies are warranted to confirm its efficacy. Supervised exercise programs improve walking impairment and quality of life (QoL) in patients with peripheral artery disease (PAD). However, such programs are underutilized, due to their limited accessibility. A feasible and effective exercise program is needed. This study assessed the feasibility of a hybrid onsite and home-based exercise program (HY-PAD) and changes in walking capacity and PAD-specific QoL following HY-PAD. Due to recruitment challenges imposed by the COVID-19 pandemic, this randomized controlled trial was modified to a pre-post intervention design that excluded the control group. Eligible patients with PAD were assigned to HY-PAD, consisting of 1-hour, supervised onsite exercise sessions 3 days per week for 4 weeks, followed by a home-based program with weekly 15-minute telephone calls to discuss exercise planning for 8 weeks. Feasibility was determined based on recruitment, adherence, and adverse events. Walking capacity was measured by a 6-minute walk test. PAD-specific QoL was assessed using the Walking Impairment Questionnaire. Of 24 patients enrolled (3 women, aged 70 ± 8 years), 21 (87.5%) completed HY-PAD. Twenty participants attended ≥ 87.5% of prescribed sessions. Two participants experienced adverse events (foot injury and limb ischemia). The 6-minute walk test distance (357 ± 105 vs 413 ± 53 meters, = 0.021), and 2 domains of the questionnaires (walking speed: 38.4 ± 24.1 vs 60.6 ± 26.6 points and stair-climbing: 60.6 ± 29.4 vs 74.0 ± 23.1 points, both < 0.001) increased significantly. High attendance and low dropout rates support the feasibility of using HY-PAD, which was associated with improved walking capacity and PAD-specific QoL. Future studies are warranted to confirm its efficacy. |
| Author | Coutinho, Thais D. Terada, Tasuku Reed, Jennifer L. Hausen, Matheus Mir, Hassan |
| Author_xml | – sequence: 1 givenname: Tasuku orcidid: 0000-0002-6623-6994 surname: Terada fullname: Terada, Tasuku organization: School of Life Sciences, Division of Physiology, Pharmacology, and Neuroscience, University of Nottingham, Nottingham, United Kingdom (current) – sequence: 2 givenname: Matheus surname: Hausen fullname: Hausen, Matheus organization: Exercise Physiology and Cardiovascular Health Lab, Division of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada – sequence: 3 givenname: Hassan surname: Mir fullname: Mir, Hassan organization: Division of Cardiology and Division of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada – sequence: 4 givenname: Jennifer L. surname: Reed fullname: Reed, Jennifer L. organization: Exercise Physiology and Cardiovascular Health Lab, Division of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada – sequence: 5 givenname: Thais D. orcidid: 0000-0002-7735-5315 surname: Coutinho fullname: Coutinho, Thais D. email: Coutinho.Thais@mayo.edu organization: Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39872645$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkl1v0zAYhSM0xMbYH-AC-XJcpPgrTjKhoWgftNIkKgYSXFmu82Z1SeNiO53yG_jTOOuYBhJwZUs-5zm2z_s82etsB0nykuAJwUS8WU30StsJxZRPcDnBJH-SHNCsKNO8xF_2Hu33kyPvVxhjygjPMvws2WdlkVPBs4PkR4Wmw8KZGn2EpVqY1gQVjO3Q3Nkbp9aosQ5Vdd8Gj25NWKI5OLNZglMtqlwAN6Bz40F5QMfTr-m8On99gqrohnRufUCzLmq20N0xr0NfDyhYVHkP3qNZhF5Gr7nLHV4kTxvVeji6Xw-Tz5cXn86m6dWH97Oz6irVGWEhzUlRiKzUCmumSQZ1sxCQC80KWjKmmlLndS2whozwRi90wVWhVM5EjkulC8YOk3c77qZfrKHW8XbxOXLjzFq5QVpl5O8nnVnKG7uVhOSCUU4i4fie4Oz3HnyQa-M1tK3qwPZeMiIwF7goeZS-ehz2kPKrgiigO4F21nsHzYOEYDlWLVdyrFqOVUtcylh1NL3dmSD-09aAk14b6DTUxoEOsrbm3_bTP-y6NZ3Rqv0GA_iV7V0XG5BEeiqxvB5naRwlyjHmnIoIOPk74H_pPwFCFNuG |
| Cites_doi | 10.1001/jama.2013.7231 10.1161/CIRCRESAHA.114.303517 10.1002/14651858.CD000990 10.1371/journal.pone.0110034 10.1161/CIRCULATIONAHA.111.075770 10.1177/1358863X211034577 10.1093/eurjpc/zwad261 10.1001/jama.2021.9941 10.1161/CIRCOUTCOMES.121.007953 10.1097/HCR.0000000000000818 10.1001/jama.1995.03530120067043 10.1016/S0741-5214(98)70034-5 10.1016/j.jvs.2008.06.050 10.1016/j.pcad.2021.12.004 10.1101/cshperspect.a029819 10.1177/1358863X211033649 10.1016/j.atherosclerosis.2008.02.002 10.1016/j.cjca.2022.02.029 10.1001/jama.2008.962 10.1161/CIR.0b013e31828b82aa 10.1016/j.jacc.2014.12.043 10.1016/j.jvs.2021.03.063 10.1177/1358863X221149454 10.1161/CIRCULATIONAHA.110.963066 10.1016/j.jacc.2010.09.053 10.1001/jamanetworkopen.2023.34590 10.1016/j.jvs.2005.01.047 10.1016/j.jvs.2022.09.014 10.1161/CIRCRESAHA.116.303566 10.1093/eurheartj/ehad734 10.1177/1358863X18762599 10.1016/j.jacc.2015.12.049 10.1097/HCR.0000000000000343 |
| ContentType | Journal Article |
| Copyright | 2024 The Authors The Authors 2024 The Authors. 2024 The Authors 2024 |
| Copyright_xml | – notice: 2024 The Authors – notice: The Authors – notice: 2024 The Authors. – notice: 2024 The Authors 2024 |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM |
| DOI | 10.1016/j.cjco.2024.09.017 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2589-790X |
| EndPage | 119 |
| ExternalDocumentID | PMC11763241 39872645 10_1016_j_cjco_2024_09_017 S2589790X24004426 1_s2_0_S2589790X24004426 |
| Genre | Journal Article |
| GroupedDBID | .1- .FO 0R~ 53G AAEDW AALRI AAXUO AAYWO ABMAC ACVFH ADCNI ADVLN AEUPX AEXQZ AFJKZ AFPUW AFRHN AFTJW AIGII AITUG AJUYK AKBMS AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP EBS EJD FDB GROUPED_DOAJ M41 M~E OK1 ROL RPM SSZ Z5R 0SF 6I. AACTN AAFTH NCXOZ AAYXX CITATION NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c513t-7188659ca0c3c15edfb6e76c382933af9c7dd60ce514fcbc84a8aa736709ac833 |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001399214100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2589-790X |
| IngestDate | Thu Aug 21 18:40:46 EDT 2025 Fri Jul 11 08:53:52 EDT 2025 Fri Jan 31 01:44:32 EST 2025 Sat Nov 29 02:56:34 EST 2025 Sat Jan 11 15:49:12 EST 2025 Wed Jun 18 06:48:25 EDT 2025 Tue Aug 26 19:36:56 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. 2024 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c513t-7188659ca0c3c15edfb6e76c382933af9c7dd60ce514fcbc84a8aa736709ac833 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Thais D. Coutinho and Jennifer L. Reed shared the senior authorship role. |
| ORCID | 0000-0002-6623-6994 0000-0002-7735-5315 |
| OpenAccessLink | http://dx.doi.org/10.1016/j.cjco.2024.09.017 |
| PMID | 39872645 |
| PQID | 3160460894 |
| PQPubID | 23479 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11763241 proquest_miscellaneous_3160460894 pubmed_primary_39872645 crossref_primary_10_1016_j_cjco_2024_09_017 elsevier_sciencedirect_doi_10_1016_j_cjco_2024_09_017 elsevier_clinicalkeyesjournals_1_s2_0_S2589790X24004426 elsevier_clinicalkey_doi_10_1016_j_cjco_2024_09_017 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-01-01 |
| PublicationDateYYYYMMDD | 2025-01-01 |
| PublicationDate_xml | – month: 01 year: 2025 text: 2025-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | CJC open (Online) |
| PublicationTitleAlternate | CJC Open |
| PublicationYear | 2025 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Divakaran, Carroll, Chen (bib38) 2021; 14 Leng, Fowler, Ernst (bib8) 2000 Gardner, Parker, Montgomery, Blevins (bib18) 2014; 3 Hiatt, Armstrong, Larson, Brass (bib1) 2015; 116 Templeton (bib25) 2011; 28 Ashor, Lara, Siervo (bib35) 2014; 9 Gardner, Parker, Montgomery (bib34) 2011; 123 Orkin, Gill, Ghersi (bib19) 2021; 326 McDermott (bib3) 2015; 116 Anderson, Halperin, Albert (bib20) 2013; 127 Cetlin, Polonsky, Ho (bib14) 2023; 77 Peñín-Grandes, López-Ortiz, Maroto-Izquierdo (bib21) 2024; 31 Gardner, Poehlman (bib9) 1995; 274 Selvin, Hirsch (bib6) 2008; 201 McDermott, Liu, Guralnik (bib24) 1998; 28 Pymer, Ibeggazene, Palmer (bib30) 2021; 74 Green, Smith (bib36) 2018; 8 Heindl, Ramirez, Joseph (bib15) 2022; 70 Gupta, Manning, Kolte (bib13) 2021; 26 Nguyen, Marzolini (bib31) 2024; 44 Olin, White, Armstrong (bib2) 2016; 67 Rehring, Sandhoff, Stolcpart (bib5) 2005; 41 Gardner, Montgomery, Wang (bib22) 2018; 23 McDermott, Ades, Guralnik (bib11) 2009; 301 Thangada, Zhang, Tian (bib16) 2023; 6 Regensteiner, Steiner, Panzer, Hiatt (bib23) 1990; 38 Lanzi, Pousaz, Calanca, Mazzolai (bib26) 2023; 28 Murphy, Cutlip, Regensteiner (bib7) 2012; 125 McDermott, Liu, Guralnik (bib28) 2013; 310 Gerhard-Herman, Gornik, Barrett (bib10) 2017; 135 Fassora, Calanca, Jaques (bib37) 2022; 27 Murphy, Cutlip, Regensteiner (bib29) 2015; 65 McDermott, Ades, Dyer (bib32) 2008; 48 Abramson, Al-Omran, Anand (bib4) 2022; 38 Mazzolai, Belch, Venermo (bib12) 2024; 45 McDermott (bib17) 2018; 38 McDermott, Liu, Ferrucci (bib27) 2011; 57 Lane, Harwood, Watson, Leng (bib33) 2017; 12 Gardner (10.1016/j.cjco.2024.09.017_bib34) 2011; 123 Gupta (10.1016/j.cjco.2024.09.017_bib13) 2021; 26 Thangada (10.1016/j.cjco.2024.09.017_bib16) 2023; 6 Nguyen (10.1016/j.cjco.2024.09.017_bib31) 2024; 44 Anderson (10.1016/j.cjco.2024.09.017_bib20) 2013; 127 Regensteiner (10.1016/j.cjco.2024.09.017_bib23) 1990; 38 Mazzolai (10.1016/j.cjco.2024.09.017_bib12) 2024; 45 Gardner (10.1016/j.cjco.2024.09.017_bib18) 2014; 3 Gardner (10.1016/j.cjco.2024.09.017_bib9) 1995; 274 Lane (10.1016/j.cjco.2024.09.017_bib33) 2017; 12 Ashor (10.1016/j.cjco.2024.09.017_bib35) 2014; 9 Olin (10.1016/j.cjco.2024.09.017_bib2) 2016; 67 McDermott (10.1016/j.cjco.2024.09.017_bib11) 2009; 301 Heindl (10.1016/j.cjco.2024.09.017_bib15) 2022; 70 Abramson (10.1016/j.cjco.2024.09.017_bib4) 2022; 38 Lanzi (10.1016/j.cjco.2024.09.017_bib26) 2023; 28 Hiatt (10.1016/j.cjco.2024.09.017_bib1) 2015; 116 Gerhard-Herman (10.1016/j.cjco.2024.09.017_bib10) 2017; 135 Fassora (10.1016/j.cjco.2024.09.017_bib37) 2022; 27 Murphy (10.1016/j.cjco.2024.09.017_bib29) 2015; 65 McDermott (10.1016/j.cjco.2024.09.017_bib3) 2015; 116 Murphy (10.1016/j.cjco.2024.09.017_bib7) 2012; 125 Divakaran (10.1016/j.cjco.2024.09.017_bib38) 2021; 14 Leng (10.1016/j.cjco.2024.09.017_bib8) 2000 Cetlin (10.1016/j.cjco.2024.09.017_bib14) 2023; 77 Templeton (10.1016/j.cjco.2024.09.017_bib25) 2011; 28 Pymer (10.1016/j.cjco.2024.09.017_bib30) 2021; 74 McDermott (10.1016/j.cjco.2024.09.017_bib28) 2013; 310 McDermott (10.1016/j.cjco.2024.09.017_bib17) 2018; 38 McDermott (10.1016/j.cjco.2024.09.017_bib24) 1998; 28 McDermott (10.1016/j.cjco.2024.09.017_bib27) 2011; 57 Orkin (10.1016/j.cjco.2024.09.017_bib19) 2021; 326 Gardner (10.1016/j.cjco.2024.09.017_bib22) 2018; 23 Selvin (10.1016/j.cjco.2024.09.017_bib6) 2008; 201 Green (10.1016/j.cjco.2024.09.017_bib36) 2018; 8 Rehring (10.1016/j.cjco.2024.09.017_bib5) 2005; 41 Peñín-Grandes (10.1016/j.cjco.2024.09.017_bib21) 2024; 31 McDermott (10.1016/j.cjco.2024.09.017_bib32) 2008; 48 |
| References_xml | – volume: 38 start-page: 63 year: 2018 end-page: 69 ident: bib17 article-title: Exercise rehabilitation for peripheral artery disease: a review publication-title: J Cardiopulm Rehabil Prev – volume: 14 start-page: e007953 year: 2021 ident: bib38 article-title: Supervised exercise therapy for symptomatic peripheral artery disease among Medicare beneficiaries between 2017 and 2018: participation rates and outcomes publication-title: Circ Cardiovasc Qual Outcomes – volume: 74 start-page: 2076 year: 2021 end-page: 2085.e2020 ident: bib30 article-title: An updated systematic review and meta-analysis of home-based exercise programs for individuals with intermittent claudication publication-title: J Vasc Surg – volume: 48 start-page: 1231 year: 2008 end-page: 1237.e1231 ident: bib32 article-title: Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease publication-title: J Vasc Surg – volume: 77 start-page: 506 year: 2023 end-page: 514 ident: bib14 article-title: Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease publication-title: J Vasc Surg – volume: 28 start-page: 1072 year: 1998 end-page: 1081 ident: bib24 article-title: Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease publication-title: J Vasc Surg – volume: 31 start-page: 380 year: 2024 end-page: 388 ident: bib21 article-title: Winners do what they fear: exercise and peripheral arterial disease—an umbrella review publication-title: Eur J Prev Cardiol – volume: 12 start-page: CD000990 year: 2017 ident: bib33 article-title: Exercise for intermittent claudication publication-title: Cochrane Database Syst Rev – volume: 41 start-page: 816 year: 2005 end-page: 822 ident: bib5 article-title: Atherosclerotic risk factor control in patients with peripheral arterial disease publication-title: J Vasc Surg – volume: 70 start-page: 175 year: 2022 end-page: 182 ident: bib15 article-title: Hybrid cardiac rehabilitation—the state of the science and the way forward publication-title: Prog Cardiovasc Dis – volume: 28 start-page: 41 year: 2011 end-page: 58 ident: bib25 article-title: A two-step approach for transforming continuous variables to normal: implications and recommendations for IS research publication-title: Commun Assoc Information Syst – volume: 3 year: 2014 ident: bib18 article-title: Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial publication-title: J Am Heart Assoc – volume: 38 start-page: A515 year: 1990 ident: bib23 article-title: Evaluation of walking impairment by questionnaire in patients with peripheral arterial-disease publication-title: Clin Res – volume: 135 start-page: e686 year: 2017 end-page: e725 ident: bib10 article-title: 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines publication-title: Circulation – volume: 38 start-page: 560 year: 2022 end-page: 587 ident: bib4 article-title: Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease publication-title: Can J Cardiol – volume: 310 start-page: 57 year: 2013 end-page: 65 ident: bib28 article-title: Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial publication-title: JAMA – volume: 127 start-page: 1425 year: 2013 end-page: 1443 ident: bib20 article-title: Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines publication-title: Circulation – volume: 28 start-page: 147 year: 2023 end-page: 149 ident: bib26 article-title: Sex-based differences in supervised exercise therapy outcomes for symptomatic peripheral artery disease publication-title: Vasc Med – volume: 201 start-page: 425 year: 2008 end-page: 433 ident: bib6 article-title: Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004 publication-title: Atherosclerosis – year: 2000 ident: bib8 article-title: Exercise for intermittent claudication publication-title: Cochrane Database Syst Rev – volume: 57 start-page: 962 year: 2011 end-page: 970 ident: bib27 article-title: Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease publication-title: J Am Coll Cardiol – volume: 45 start-page: 1303 year: 2024 end-page: 1321 ident: bib12 article-title: Exercise therapy for chronic symptomatic peripheral artery disease publication-title: Eur Heart J – volume: 44 start-page: 55 year: 2024 end-page: 63 ident: bib31 article-title: Pre-participation withdrawal and noncompletion of cardiac rehabilitation in peripheral artery disease: matched comparisons to coronary artery disease publication-title: J Cardiopulm Rehabil Prev – volume: 123 start-page: 491 year: 2011 end-page: 498 ident: bib34 article-title: Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial publication-title: Circulation – volume: 301 start-page: 165 year: 2009 end-page: 174 ident: bib11 article-title: Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial publication-title: JAMA – volume: 9 start-page: e110034 year: 2014 ident: bib35 article-title: Effects of exercise modalities on arterial stiffness and wave reflection: a systematic review and meta-analysis of randomized controlled trials publication-title: PLoS One – volume: 67 start-page: 1338 year: 2016 end-page: 1357 ident: bib2 article-title: Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options publication-title: J Am Coll Cardiol – volume: 125 start-page: 130 year: 2012 end-page: 139 ident: bib7 article-title: Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study publication-title: Circulation – volume: 26 start-page: 654 year: 2021 end-page: 656 ident: bib13 article-title: Exercise therapy referral and participation in patients with peripheral artery disease: insights from the PORTRAIT registry publication-title: Vasc Med – volume: 65 start-page: 999 year: 2015 end-page: 1009 ident: bib29 article-title: Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study publication-title: J Am Coll Cardiol – volume: 116 start-page: 1527 year: 2015 end-page: 1539 ident: bib1 article-title: Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease publication-title: Circ Res – volume: 326 start-page: 257 year: 2021 end-page: 265 ident: bib19 article-title: Guidelines for reporting trial protocols and completed trials modified due to the COVID-19 pandemic and other extenuating circumstances: the CONSERVE 2021 statement publication-title: JAMA – volume: 27 start-page: 158 year: 2022 end-page: 170 ident: bib37 article-title: Intensity-dependent effects of exercise therapy on walking performance and aerobic fitness in symptomatic patients with lower-extremity peripheral artery disease: a systematic review and meta-analysis publication-title: Vasc Med – volume: 274 start-page: 975 year: 1995 end-page: 980 ident: bib9 article-title: Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis publication-title: JAMA – volume: 8 start-page: a029819 year: 2018 ident: bib36 article-title: Effects of exercise on vascular function, structure, and health in humans publication-title: Cold Spring Harb Perspect Med – volume: 6 year: 2023 ident: bib16 article-title: Home-based walking exercise and supervised treadmill exercise in patients with peripheral artery disease: an individual participant data meta-analysis publication-title: JAMA Netw Open – volume: 116 start-page: 1540 year: 2015 end-page: 1550 ident: bib3 article-title: Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia publication-title: Circ Res – volume: 23 start-page: 349 year: 2018 end-page: 357 ident: bib22 article-title: Minimal clinically important differences in treadmill, 6-minute walk, and patient-based outcomes following supervised and home-based exercise in peripheral artery disease publication-title: Vasc Med – volume: 310 start-page: 57 year: 2013 ident: 10.1016/j.cjco.2024.09.017_bib28 article-title: Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2013.7231 – volume: 116 start-page: 1540 year: 2015 ident: 10.1016/j.cjco.2024.09.017_bib3 article-title: Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia publication-title: Circ Res doi: 10.1161/CIRCRESAHA.114.303517 – year: 2000 ident: 10.1016/j.cjco.2024.09.017_bib8 article-title: Exercise for intermittent claudication publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD000990 – volume: 38 start-page: A515 year: 1990 ident: 10.1016/j.cjco.2024.09.017_bib23 article-title: Evaluation of walking impairment by questionnaire in patients with peripheral arterial-disease publication-title: Clin Res – volume: 9 start-page: e110034 year: 2014 ident: 10.1016/j.cjco.2024.09.017_bib35 article-title: Effects of exercise modalities on arterial stiffness and wave reflection: a systematic review and meta-analysis of randomized controlled trials publication-title: PLoS One doi: 10.1371/journal.pone.0110034 – volume: 125 start-page: 130 year: 2012 ident: 10.1016/j.cjco.2024.09.017_bib7 article-title: Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.075770 – volume: 27 start-page: 158 year: 2022 ident: 10.1016/j.cjco.2024.09.017_bib37 article-title: Intensity-dependent effects of exercise therapy on walking performance and aerobic fitness in symptomatic patients with lower-extremity peripheral artery disease: a systematic review and meta-analysis publication-title: Vasc Med doi: 10.1177/1358863X211034577 – volume: 31 start-page: 380 year: 2024 ident: 10.1016/j.cjco.2024.09.017_bib21 article-title: Winners do what they fear: exercise and peripheral arterial disease—an umbrella review publication-title: Eur J Prev Cardiol doi: 10.1093/eurjpc/zwad261 – volume: 326 start-page: 257 year: 2021 ident: 10.1016/j.cjco.2024.09.017_bib19 article-title: Guidelines for reporting trial protocols and completed trials modified due to the COVID-19 pandemic and other extenuating circumstances: the CONSERVE 2021 statement publication-title: JAMA doi: 10.1001/jama.2021.9941 – volume: 14 start-page: e007953 year: 2021 ident: 10.1016/j.cjco.2024.09.017_bib38 article-title: Supervised exercise therapy for symptomatic peripheral artery disease among Medicare beneficiaries between 2017 and 2018: participation rates and outcomes publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/CIRCOUTCOMES.121.007953 – volume: 44 start-page: 55 year: 2024 ident: 10.1016/j.cjco.2024.09.017_bib31 article-title: Pre-participation withdrawal and noncompletion of cardiac rehabilitation in peripheral artery disease: matched comparisons to coronary artery disease publication-title: J Cardiopulm Rehabil Prev doi: 10.1097/HCR.0000000000000818 – volume: 274 start-page: 975 year: 1995 ident: 10.1016/j.cjco.2024.09.017_bib9 article-title: Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis publication-title: JAMA doi: 10.1001/jama.1995.03530120067043 – volume: 28 start-page: 1072 year: 1998 ident: 10.1016/j.cjco.2024.09.017_bib24 article-title: Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease publication-title: J Vasc Surg doi: 10.1016/S0741-5214(98)70034-5 – volume: 48 start-page: 1231 year: 2008 ident: 10.1016/j.cjco.2024.09.017_bib32 article-title: Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease publication-title: J Vasc Surg doi: 10.1016/j.jvs.2008.06.050 – volume: 70 start-page: 175 year: 2022 ident: 10.1016/j.cjco.2024.09.017_bib15 article-title: Hybrid cardiac rehabilitation—the state of the science and the way forward publication-title: Prog Cardiovasc Dis doi: 10.1016/j.pcad.2021.12.004 – volume: 3 year: 2014 ident: 10.1016/j.cjco.2024.09.017_bib18 article-title: Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial publication-title: J Am Heart Assoc – volume: 8 start-page: a029819 year: 2018 ident: 10.1016/j.cjco.2024.09.017_bib36 article-title: Effects of exercise on vascular function, structure, and health in humans publication-title: Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a029819 – volume: 26 start-page: 654 year: 2021 ident: 10.1016/j.cjco.2024.09.017_bib13 article-title: Exercise therapy referral and participation in patients with peripheral artery disease: insights from the PORTRAIT registry publication-title: Vasc Med doi: 10.1177/1358863X211033649 – volume: 28 start-page: 41 year: 2011 ident: 10.1016/j.cjco.2024.09.017_bib25 article-title: A two-step approach for transforming continuous variables to normal: implications and recommendations for IS research publication-title: Commun Assoc Information Syst – volume: 135 start-page: e686 year: 2017 ident: 10.1016/j.cjco.2024.09.017_bib10 article-title: 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines publication-title: Circulation – volume: 201 start-page: 425 year: 2008 ident: 10.1016/j.cjco.2024.09.017_bib6 article-title: Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2008.02.002 – volume: 38 start-page: 560 year: 2022 ident: 10.1016/j.cjco.2024.09.017_bib4 article-title: Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease publication-title: Can J Cardiol doi: 10.1016/j.cjca.2022.02.029 – volume: 301 start-page: 165 year: 2009 ident: 10.1016/j.cjco.2024.09.017_bib11 article-title: Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial publication-title: JAMA doi: 10.1001/jama.2008.962 – volume: 127 start-page: 1425 year: 2013 ident: 10.1016/j.cjco.2024.09.017_bib20 article-title: Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines publication-title: Circulation doi: 10.1161/CIR.0b013e31828b82aa – volume: 65 start-page: 999 year: 2015 ident: 10.1016/j.cjco.2024.09.017_bib29 article-title: Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.12.043 – volume: 74 start-page: 2076 year: 2021 ident: 10.1016/j.cjco.2024.09.017_bib30 article-title: An updated systematic review and meta-analysis of home-based exercise programs for individuals with intermittent claudication publication-title: J Vasc Surg doi: 10.1016/j.jvs.2021.03.063 – volume: 28 start-page: 147 year: 2023 ident: 10.1016/j.cjco.2024.09.017_bib26 article-title: Sex-based differences in supervised exercise therapy outcomes for symptomatic peripheral artery disease publication-title: Vasc Med doi: 10.1177/1358863X221149454 – volume: 123 start-page: 491 year: 2011 ident: 10.1016/j.cjco.2024.09.017_bib34 article-title: Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.110.963066 – volume: 57 start-page: 962 year: 2011 ident: 10.1016/j.cjco.2024.09.017_bib27 article-title: Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.09.053 – volume: 6 year: 2023 ident: 10.1016/j.cjco.2024.09.017_bib16 article-title: Home-based walking exercise and supervised treadmill exercise in patients with peripheral artery disease: an individual participant data meta-analysis publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2023.34590 – volume: 41 start-page: 816 year: 2005 ident: 10.1016/j.cjco.2024.09.017_bib5 article-title: Atherosclerotic risk factor control in patients with peripheral arterial disease publication-title: J Vasc Surg doi: 10.1016/j.jvs.2005.01.047 – volume: 77 start-page: 506 year: 2023 ident: 10.1016/j.cjco.2024.09.017_bib14 article-title: Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease publication-title: J Vasc Surg doi: 10.1016/j.jvs.2022.09.014 – volume: 116 start-page: 1527 year: 2015 ident: 10.1016/j.cjco.2024.09.017_bib1 article-title: Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease publication-title: Circ Res doi: 10.1161/CIRCRESAHA.116.303566 – volume: 45 start-page: 1303 year: 2024 ident: 10.1016/j.cjco.2024.09.017_bib12 article-title: Exercise therapy for chronic symptomatic peripheral artery disease publication-title: Eur Heart J doi: 10.1093/eurheartj/ehad734 – volume: 23 start-page: 349 year: 2018 ident: 10.1016/j.cjco.2024.09.017_bib22 article-title: Minimal clinically important differences in treadmill, 6-minute walk, and patient-based outcomes following supervised and home-based exercise in peripheral artery disease publication-title: Vasc Med doi: 10.1177/1358863X18762599 – volume: 67 start-page: 1338 year: 2016 ident: 10.1016/j.cjco.2024.09.017_bib2 article-title: Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.12.049 – volume: 38 start-page: 63 year: 2018 ident: 10.1016/j.cjco.2024.09.017_bib17 article-title: Exercise rehabilitation for peripheral artery disease: a review publication-title: J Cardiopulm Rehabil Prev doi: 10.1097/HCR.0000000000000343 – volume: 12 start-page: CD000990 year: 2017 ident: 10.1016/j.cjco.2024.09.017_bib33 article-title: Exercise for intermittent claudication publication-title: Cochrane Database Syst Rev |
| SSID | ssj0002314550 |
| Score | 2.2786655 |
| Snippet | Supervised exercise programs improve walking impairment and quality of life (QoL) in patients with peripheral artery disease (PAD). However, such programs are... AbstractBackgroundSupervised exercise programs improve walking impairment and quality of life (QoL) in patients with peripheral artery disease (PAD). However,... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 110 |
| SubjectTerms | Cardiovascular Peripheral Vascular Disease |
| Title | A Hybrid Rehabilitation Program for Adults with Peripheral Artery Disease (HY-PAD): A Pre-Post Intervention Study to Assess Its Feasibility |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2589790X24004426 https://www.clinicalkey.es/playcontent/1-s2.0-S2589790X24004426 https://dx.doi.org/10.1016/j.cjco.2024.09.017 https://www.ncbi.nlm.nih.gov/pubmed/39872645 https://www.proquest.com/docview/3160460894 https://pubmed.ncbi.nlm.nih.gov/PMC11763241 |
| Volume | 7 |
| WOSCitedRecordID | wos001399214100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ (Directory of Open Access Journals) customDbUrl: eissn: 2589-790X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002314550 issn: 2589-790X databaseCode: DOA dateStart: 20190101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2589-790X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002314550 issn: 2589-790X databaseCode: M~E dateStart: 20190101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF2lBSFeEHfCJVokQKDIyPb6sstbFFoF1JSIpig8rTbrtUip3JBL1b7wA_wP38eMd51LW6A88GJFTnyJ53j27OyZGUKeZSLJhUpiL4lz5kUxVx7XLPOM72cxT8OElVmun3bS3V0-GIherfazyoU5PkyLgp-ciPF_NTXsA2Nj6uw_mHtxUtgBn8HosAWzw_ZShm81O6eYhgVPbrUIN6YEoBKr1BW2sOqGS2zrwU2VtQUOMVJvJqdYkRMXbZB8dj57vdbb56GwGey9ifGwva8NJFZSyb2yMDWQWLuC3HwHpwZq6YS3a-vG7fftJjbsOlvl1OmbJyoryWxfTedf50vvWMWJushX54tpQHdU4q0DE4AlyD8aG7-tdDsur8JFNsJ4JbJROsAw5sJLhT-wY9UF-5wHT88B1XrjwCpmz40SNmBx8FofaMz_DG2pW5tDul6Se_eD3N7f2ZH9rUH_xfibh93KcFXftW7ZIFfCNBboTbvfl7E94MyYLI59DavbdflaVlp49rq_40Tn5zxnpbsrXKh_k9xwkxjasuC7RWqmuE2udZ1M4w750aIWg3Qdg9RhkAIGqcUgRQzSJQapxSB1GKQvLQJfvaEtWqGPrqKPluijsyNq0UcBfXQFfXfJ_vZWv93xXNcPT8cBm3lAlngSC618zXQQmywfJiZNNOPATJnKhU6zLPG1Aaqf66HmkeJKpWUhQqU5Y_fIZnFUmAeEDtUwj0I1zPLQRLDlOFnQSvt5xrgxrE6a1XOXY1vcRVaqxwOJVpJoJekLCVaqE1aZRlZpyzDQSkDVH49KLzrKTJ3LmMpATkPpyz3ECkIFVd0REOc6iRdHOjpsae5fr_i0wo2EsQIXAFVhjuZTyYIEdRBcRHVy3-Jo8b-ZQM8cxXXC1xC2-AHWoV__phh9KevRB0GKTR-Ch5e48CNyffmqPyabs8ncPCFX9fFsNJ00yEY64I0yLtYoX6lfv50AaQ |
| linkProvider | ISSN International Centre |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Hybrid+Rehabilitation+Program+for+Adults+with+Peripheral+Artery+Disease+%28HY-PAD%29%3A+A+Pre-Post+Intervention+Study+to+Assess+Its+Feasibility&rft.jtitle=CJC+open+%28Online%29&rft.au=Terada%2C+Tasuku&rft.au=Hausen%2C+Matheus&rft.au=Mir%2C+Hassan&rft.au=Reed%2C+Jennifer+L&rft.date=2025-01-01&rft.issn=2589-790X&rft.eissn=2589-790X&rft.volume=7&rft.issue=1&rft.spage=110&rft_id=info:doi/10.1016%2Fj.cjco.2024.09.017&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F2589790X%2FS2589790X24X00153%2Fcov150h.gif |